The Biotechnology Innovation Organization is calling on those involved in the development, review, approval and distribution of COVID-19 therapeutics and vaccines to commit to a set of principles to ensure public trust in these products.
BIO described these principles for assessing COVID-19 clinical trial data and determining their potential value in a 3 September







